Porth's Essentials of Pathophysiology, 4e

260

Hematopoietic Function

U N I T 3

28. American Cancer Society. Acute myeloid leukemia. 2013. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003110-pdf.pdf. Accessed September 21, 2013. 29. Krug U, Búchner T, Burdel WE, et al. The treatment of elderly patients with acute myeloid leukemia. Dtsch Arziebi Int. 2011;108(51–52):863–870. 30. American Cancer Society. Chronic lymphocytic leukemia. 2013. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003111-pdf.pdf. Accessed September 21, 2013. 31. Chiorazzi N, Rai KR, Farrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804–815. 32. Malayssi F, Deaglio S, Damie G. CD38 and chronic lymphocytic leukemia: a decade later. Blood. 2011;119(3):2470–3478. 33. American Cancer Society. Chronic myeloid leukemia. 2012. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003112-pdf.pdf. Accessed September 21, 2013. 34. Chen Y, Peng C, Sullivan C, et al. Critical molecular pathways in cancer stem cells of chronic myeloid leukemia. Leukemia. 2010;24(9):1545–1554. 35. Cervantes F, Mauro M. Practical management of chronic myeloid leukemia. Cancer. 2011;117:4343–4354. 36. Marin D. Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia. Hematology. 2012:115–121. 37. Mahon F-X. Is going for a cure in chronic myeloid leukemia possible and justified. Hematology. 2012:122–128. 38. Goldman JM, Melo JV. Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451–1464. 39. Rademaker J. Hodgkin’s and non-Hodgkin’s lymphoma. Radiol Clin North Am. 2007;45:69–83. 40. American Cancer Society. Non-Hodgkin lymphoma. 2013. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003126-pdf.pdf. Accessed September 21, 2013. 41. Armitage JO. Staging of non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55:368–376. 42. Lenz C, Staudt LM. Aggressive lymphomas. N Engl J Med. 2010;362(15):1417–1429.

43. Reiser M, Diehl V. Current treatment of follicular non-Hodgkin’s lymphoma. Eur J Cancer. 2002;38:1167–1172. 44. American Cancer Society. Hodgkin disease. 2012. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003105-pdf.pdf. Accessed September 21, 2013. 45. Yung L, Linch D. Hodgkin’s lymphoma. Lancet 2003;361:943–951. 46. Conners JM. Hodgkin's lymphoma—the great teacher. N Engl J Med. 2011;365(3):264–265. 47. Armitage JO. Early-stage Hodgkin’s lymphoma. N Engl J Med. 2010;363(7):653–662. 48. American Cancer Society. Multiple myeloma. 2013. Available at: http://www.cancer.org/acs/groups/cid/documents/ webcontent/003126-pdf.pdf. Accessed September 21, 2013. 49. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–1060. 50. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet. 2009;374:324–339. 51. Nau KC, Lewis WD. Multiple myeloma: diagnosis and treatment. Am Fam Physician. 2008;78(7):853–860. 52. Katzel JA. Multiple myeloma: charging toward a bright future. CA Cancer J Clin. 2007;57:301–318.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •   NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu